NCT06929598 Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents
| NCT ID | NCT06929598 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tel Aviv University |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-01 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if adding Shiatsu therapy to standard treatment can improve quality of life in children and adolescents with chronic pain that is not caused by inflammation. The main question it aims to answer is: Does Shiatsu therapy help improve the quality of life in children with long-lasting pain? All participants will continue their regular treatment and will also: * Receive a 30-minute Shiatsu session once a week for six weeks * Complete questionnaires about their quality of life and family impact before, during, and after the treatment period The study includes about 40 participants between the ages of 10 and 18, who are already being followed at the pediatric pain and rheumatology clinics at Tel Aviv Sourasky Medical Center.
Eligibility Criteria
Inclusion Criteria: * Children and adolescents aged 10-18 years * Diagnosed with non-inflammatory chronic pain syndromes * Actively followed by the Pediatric Rheumatology and/or Pediatric Pain Clinics at Tel Aviv Sourasky Medical Center (at least twice a year) * Informed consent signed by at least one legal guardian (or both guardians in cases of separated parents) * If participant is 16 years or older, they must also sign the informed consent Exclusion Criteria: * Informed consent cannot be obtained from the participant or their legal guardians * Legal guardians unable to provide informed consent * Patients with severe conditions (e.g., bone metastasis) * Patients unable to participate in Shiatsu therapy sessions * Participation in Shiatsu therapy within 6 months prior to study enrollment * Participant or legal guardian refuses participation
Contact & Investigator
Merav Heshin-Bekenstein, MD
PRINCIPAL INVESTIGATOR
Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel
Frequently Asked Questions
Who can join the NCT06929598 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06929598 currently recruiting?
Yes, NCT06929598 is actively recruiting participants. Contact the research team at cohensela@mail.tau.ac.il for enrollment information.
Where is the NCT06929598 trial being conducted?
This trial is being conducted at Tel Aviv, Israel, Tel Aviv, Israel.
Who is sponsoring the NCT06929598 clinical trial?
NCT06929598 is sponsored by Tel Aviv University. The principal investigator is Merav Heshin-Bekenstein, MD at Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.